Indiana University Foundation, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1820-01-20

Employees: 10K

Market Cap: -

Website: http://www.indiana.edu

Clinical Trials

Phase II Study of Gleevec/Imatinib Mesylate (STI-571, NCS 716051) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas

Phase 2

Completed

Conditions: Neurofibromatosis

Interventions: Drug: Gleevec

First Posted Date: 2012-08-27

Last Posted Date: 2016-04-06

Lead Sponsor: Indiana University

Target Recruit Count: 36

Registration Number: NCT01673009

Locations: 🇺🇸
Indiana University, Indianapolis, Indiana, United States

Very Low Calorie Diet for Diabetic Kidney Disease

Not Applicable

Completed

Conditions: Diabetic Kidney Disease

Interventions: Other: very low calorie diet

First Posted Date: 2012-08-24

Last Posted Date: 2015-08-28

Lead Sponsor: Indiana University

Target Recruit Count: 10

Registration Number: NCT01671969

Locations: 🇺🇸
University Hospital, Indianapolis, Indiana, United States

Endoscopic Ultrasound (EUS)-Guided Ablation of Pancreatic Cysts

Not Applicable

Completed

Conditions: Pancreatic Cyst
Pancreatic Intraductal Papillary-Mucinous Neoplasm
Cystadenoma, Mucinous
Papillary Mucinous Cystadenoma, Borderline Malignancy

Interventions: Procedure: 98% Ethanol & Paclitaxel injection

First Posted Date: 2012-07-18

Last Posted Date: 2022-04-14

Lead Sponsor: Indiana University

Target Recruit Count: 33

Registration Number: NCT01643460

Locations: 🇺🇸
Indiana University Hospital, Indianapolis, Indiana, United States

Anti-INFLammatory to Address Mood and Endothelial Dysfunction (INFLAMED)

Phase 2

Completed

Conditions: Major Depressive Disorder
Depression
Depressive Symptoms
Cardiovascular Disease (CVD)
Coronary Artery Disease (CAD)
Heart Disease

Interventions: Other: Placebo
Drug: Pentoxifylline
Behavioral: Standard Treatment

First Posted Date: 2012-06-21

Last Posted Date: 2015-12-03

Lead Sponsor: Indiana University

Target Recruit Count: 36

Registration Number: NCT01625845

Locations: 🇺🇸
Indiana University-Purdue University Indianapolis (IUPUI), Indianapolis, Indiana, United States

Prevalence of Pancreatic Cysts During Routine Endoscopic Ultra Sound

Completed

Conditions: Pancreatic Cysts

First Posted Date: 2012-06-20

Last Posted Date: 2017-04-20

Lead Sponsor: Indiana University

Target Recruit Count: 341

Registration Number: NCT01624363

Locations: 🇺🇸
University Hospital, Indianapolis, Indiana, United States

Study of the Effectiveness of a Computer Decision Support System to Improve Physicians' Screening for Autism

Not Applicable

Completed

Conditions: Healthy Children Undergoing Routine Care
Children With Autism

Interventions: Other: Computer based care reminders

First Posted Date: 2012-06-06

Last Posted Date: 2015-03-24

Lead Sponsor: Indiana University

Target Recruit Count: 368

Registration Number: NCT01612897

Locations: 🇺🇸
Wishard (Eskenazi) Healthcare clinics, Indianapolis, Indiana, United States

Antiplatelet Therapy Guided by Thrombelastography in Patients With Acute Coronary Syndromes (TEGCOR Study)

Phase 4

Terminated

Conditions: Thrombosis
Coronary Artery Disease

Interventions: Drug: Prasugrel
Drug: Clopidogrel

First Posted Date: 2012-06-06

Last Posted Date: 2018-04-26

Lead Sponsor: Indiana University

Target Recruit Count: 67

Registration Number: NCT01612884

Locations: 🇺🇸
Eskenazi Health, Indianapolis, Indiana, United States
🇺🇸
Indiana University Health Methodist Hospital, Indianapolis, Indiana, United States

Modulation of Human Myocardial Metabolism by GLP-1 Dose Response

Phase 2

Completed

Conditions: Type 2 Diabetes Mellitus
Healthy

Interventions: Drug: Saline
Drug: GLP-1 Low Dose
Drug: GLP-1 Mid-Range Dose
Drug: GLP-1 High Dose

First Posted Date: 2012-05-30

Last Posted Date: 2016-02-17

Lead Sponsor: Indiana University

Target Recruit Count: 33

Registration Number: NCT01607450

Locations: 🇺🇸
Indiana Clinical Research Center, Indianapolis, Indiana, United States

Beating the Blues for Your Heart

Phase 2

Completed

Conditions: Depressive Symptoms
Cardiovascular Disease (CVD)
Heart Disease
Depression
Coronary Artery Disease (CAD)

Interventions: Behavioral: Beating the Blues (BtB)
Other: Usual Care

First Posted Date: 2012-05-25

Last Posted Date: 2022-12-29

Lead Sponsor: Indiana University

Target Recruit Count: 29

Registration Number: NCT01605552

Locations: 🇺🇸
Indiana University-Purdue University Indianapolis (IUPUI), Indianapolis, Indiana, United States

Efavirenz Versus Rilpivirine on Vascular Function, Inflammation, and Oxidative Stress

Phase 4

Completed

Conditions: Cardiovascular Disease

Interventions: Drug: Rilpivirine
Drug: Efavirenz

First Posted Date: 2012-04-25

Last Posted Date: 2015-08-14

Lead Sponsor: Indiana University

Target Recruit Count: 40

Registration Number: NCT01585038

Locations: 🇺🇸
Indiana Clinical and Translational Sciences Institute, Indianapolis, Indiana, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy